Medical
Research.com Interview with
Jagpreet Chhatwal, Ph.D.
Assistant Professor
Department of Health Services Research
Houston, TX 77098
Medical Research: What are the main findings of the study?
Dr. Chhatwal: The recent updates in hepatitis C virus (HCV) screening policy and ongoing therapeutic advances can make hepatitis C a rare disease in the US by 2036. However, more aggressive screening strategies are needed to further reduce the burden of disease. For example, 1-time universal screening further identify 487,000 chronic
hepatitis C virus cases in the next 10 years, and can make hepatitis C a rare disease in the next 12 years.
MedicalResearch.com Interview with:
Dr Daniel Bradshaw
Chelsea and Westminster Hospital, London
Medical Research: What are the main findings of the study?
Dr. Bradshaw: Over 40% of men with hepatitis C (HCV) infection have HCV RNA in their semen, although the level of RNA was much lower than blood (usually 4 log less than blood).
Neither HIV nor acute hepatitis C led to increased shedding of HCV RNA in semen. Interestingly, however, in acute HCV, HIV-positive men with higher blood levels of HCV RNA were more likely to shed RNA in their semen.